Melphalan
Melphalan is a chemotherapeutic agent used in the treatment of a variety of cancers, including melanoma[1] and multiple myeloma.[2]
Melphalan Media
Mechanism of nucleotide alkylation by melphalan
Syntheses: U.S. Patent 3,032,584; U.S. Patent 3,032,585 (both 1962 to NRDC).
References
- ↑ "Percutaneous hepatic perfusion with melphalan improved hepatic PFS in ocular, cutaneous melanoma | Hematology Oncology". Hemonctoday.com. Retrieved 2014-06-24.
- ↑ Lua error in Module:Citation/CS1/Identifiers at line 630: attempt to index field 'known_free_doi_registrants_t' (a nil value).
